Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Boucher

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Opinion in Infectious Diseases|November 1, 2006
New agents for Staphylococcus aureus endocarditisMarci Drees, Helen Boucher
The American Journal of Emergency Medicine|August 18, 2009
Rifampin-containing regimens for community-associated skin infection: a hazard without known benefitLoren G Miller, Helen Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2010
Serious infections caused by methicillin-resistant Staphylococcus aureusHelen Boucher, Loren G Miller, Raymund R Razonable
Annals of Emergency Medicine|January 22, 2011
To treat or not to treat: adjunctive antibiotics for uncomplicated abscessesBrad Spellberg, Helen Boucher, John Bradley, et al.
Diagnostic Microbiology and Infectious Disease|July 4, 2012
First report of a left ventricular assist device infection caused by Staphylococcus schleiferi subspecies coagulans: a coagulase-positive organismEvangeline Thibodeau, Helen Boucher, David Denofrio, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 17, 2015
BK Virus Nephropathy in Heart Transplant RecipientsAlin Joseph, Monika Pilichowska, Helen Boucher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2012
Progress on developing endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: update from the Biomarkers Consortium of the Foundation for the National Institutes of HealthGeorge H Talbot, John H Powers, Thomas R Fleming, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2008
Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolatesSusan J Rehm, Helen Boucher, Donald Levine, et al.
Pharmacotherapy|November 19, 2016
Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal ImplicationsKatherine H Luepke, Katie J Suda, Helen Boucher, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 2, 2010
Daptomycin compared to standard therapy for the treatment of native valve endocarditisZeina Kanafani, Helen Boucher, Vance Fowler, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Opinion in Infectious Diseases|November 1, 2006
New agents for Staphylococcus aureus endocarditisMarci Drees, Helen Boucher
The American Journal of Emergency Medicine|August 18, 2009
Rifampin-containing regimens for community-associated skin infection: a hazard without known benefitLoren G Miller, Helen Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2010
Serious infections caused by methicillin-resistant Staphylococcus aureusHelen Boucher, Loren G Miller, Raymund R Razonable
Annals of Emergency Medicine|January 22, 2011
To treat or not to treat: adjunctive antibiotics for uncomplicated abscessesBrad Spellberg, Helen Boucher, John Bradley, et al.
Diagnostic Microbiology and Infectious Disease|July 4, 2012
First report of a left ventricular assist device infection caused by Staphylococcus schleiferi subspecies coagulans: a coagulase-positive organismEvangeline Thibodeau, Helen Boucher, David Denofrio, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 17, 2015
BK Virus Nephropathy in Heart Transplant RecipientsAlin Joseph, Monika Pilichowska, Helen Boucher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2012
Progress on developing endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: update from the Biomarkers Consortium of the Foundation for the National Institutes of HealthGeorge H Talbot, John H Powers, Thomas R Fleming, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2008
Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolatesSusan J Rehm, Helen Boucher, Donald Levine, et al.
Pharmacotherapy|November 19, 2016
Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal ImplicationsKatherine H Luepke, Katie J Suda, Helen Boucher, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 2, 2010
Daptomycin compared to standard therapy for the treatment of native valve endocarditisZeina Kanafani, Helen Boucher, Vance Fowler, et al.
Pageof 2